Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2021 Sep 1;16(9):e0257142.
doi: 10.1371/journal.pone.0257142. eCollection 2021.

Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

Published Erratum

Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

Paul Jank et al. PLoS One. .

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0238021.].

PubMed Disclaimer

Erratum for

  • MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
    Jank P, Gehlhaar C, Bianca L, Caterina F, Andreas S, Karn T, Marmé F, Sinn HP, van Mackelenbergh M, Sinn B, Zahm DM, Ingold-Heppner B, Schem C, Stickeler E, Fasching PA, Nekljudova V, Taube ET, Heppner F, Müller V, Denkert C, Loibl S. Jank P, et al. PLoS One. 2020 Aug 25;15(8):e0238021. doi: 10.1371/journal.pone.0238021. eCollection 2020. PLoS One. 2020. PMID: 32841306 Free PMC article.

References

    1. Jank P, Gehlhaar C, Bianca L, Caterina F, Andreas S, Karn T, et al. (2020) MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial. PLoS ONE 15(8): e0238021. 10.1371/journal.pone.0238021 - DOI - PMC - PubMed

Publication types